BPC-157: Cytoprotection and Tissue Repair in Preclinical Models

Body Protection Compound-157 (BPC-157) is a synthetic pentadecapeptide derived from a partial sequence of a gastric protein originally isolated from rodent gastric juice [1]. Across two decades of preclinical investigation, the molecule has become a workhorse research tool for studying cytoprotection, angiogenesis, and connective-tissue repair in cell-culture and animal models.

Mechanistically, the most consistent findings concern modulation of the nitric-oxide (NO) system and upregulation of growth-factor receptors. In a rodent Achilles tendon transection model, intraperitoneal administration accelerated tenocyte proliferation and outgrowth and was associated with increased expression of the growth-hormone receptor on tendon fibroblasts [2]. In rat models of medial collateral ligament injury, treated animals showed faster organization of collagen fibrils on histology versus saline controls [3].

BPC-157 has also been characterized for vascular effects relevant to tissue repair. In rodent models of vascular occlusion, treatment produced rapid recruitment of alternative collateral vessels — a phenomenon Sikiric and colleagues have termed “bypassing key” pathway activation [4]. In cultured endothelial cells, BPC-157 promoted tube formation and migration in a VEGFR2-dependent manner, suggesting a direct pro-angiogenic signal [5].

A separate body of literature documents gastrointestinal cytoprotection. In rodent models of NSAID-induced gastric lesions and induced colitis, BPC-157 reduced mucosal damage and accelerated epithelial restitution [6].

Researchers studying these pathways frequently use lyophilized peptide reconstituted in sterile water or bacteriostatic water for in vitro and in vivo work. Frontier Peptide Labs supplies a research-grade BPC-157 10 mg vial with third-party HPLC purity reports for laboratory use only.

References

1. Sikiric P, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2011;17(16):1612-32. PubMed: 21548867
2. Krivic A, et al. Achilles detachment in rat and stable gastric pentadecapeptide BPC 157. J Orthop Res. 2006;24(5):982-9. PubMed: 16583442
3. Cerovecki T, et al. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthop Res. 2010;28(9):1155-61. PubMed: 20225319
4. Sikiric P, et al. Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats. Eur J Pharmacol. 2018;818:457-466. DOI: 10.1016/j.ejphar.2017.11.001
5. Hsieh MJ, et al. Therapeutic potential of pro-angiogenic BPC 157 in ischemia/reperfusion. Vascul Pharmacol. 2017;94-95:1-10. DOI: 10.1016/j.vph.2017.04.005
6. Sikiric P, et al. BPC 157 and the central nervous system. Neural Regen Res. 2022;17(3):482-487. PubMed: 34380875